Financial Markets
Real Estate
Local listed Company
Overseas-listed Company
Foreign Company
Industrial Parks

Company - Domestic
 Search News  Or
Yunnan Baiyao's H1 profit up 28%

Aug. 16, 2012 (China Knowledge) - Yunnan Baiyao Group Co Ltd<000538>, one of China's leading pharmaceutical firms, booked RMB 724.53 million in net profit attributable to shareholders in the first half of this year, 28.44% more than in the same period of last year, according to a statement filed with the Shenzhen Stock Exchange.

Basic earnings per share for the period were RMB 1.04, RMB 0.23 more than it realized in the first half of 2011.

From January to June 2012, the Shenzhen listed pharmaceutical company saw its operation revenue reach RMB 6.08 billion, up 19.74% from a year earlier.

Operating revenue in core businesses exceeded RMB 6.06 billion in the six-month period, comprising RMB 6.02 billion from domestic market and RMB 38.96 million from overseas market, up 19.19% and 165.9% from a year earlier, respectively.

Add this     
Copyright © "2015"

Send feedback or comments to:

For more news, financial weekly reports, business guides to China, Market Research Reports and other premium information, subscribe to China Knowledge today

To access our page on Bloomberg, type CKFI (GO)

 Our Professional Services


 News Archive
About Us | CSR | Media Center | E-Newsletter | E-Store | Contact Us | Feedback | Sitemap | Privacy Policy | Terms of Use  

           Copyright © 2014 China Knowledge Online. All Rights Reserved